» Articles » PMID: 22019801

Wells' Syndrome (eosinophilic Cellulitis) Secondary to Infliximab

Overview
Specialty Rheumatology
Date 2011 Oct 25
PMID 22019801
Citations 12
Authors
Affiliations
Soon will be listed here.
Citing Articles

Wells Syndrome: A Rare Skin Manifestation of Non-Hodgkin's Lymphoma.

Jose A, Raj M, Jose M, Mg J Cureus. 2024; 16(10):e71150.

PMID: 39525186 PMC: 11546749. DOI: 10.7759/cureus.71150.


Paradoxical and bimodal immune-mediated dermatological side effects of TNF-α inhibitors: A comprehensive review.

Behrangi E, Moodi F, Jafarzadeh A, Goodarzi A Skin Res Technol. 2024; 30(5):e13718.

PMID: 38700458 PMC: 11067872. DOI: 10.1111/srt.13718.


Eosinophilic Gastroenteritis in an Ulcerative Colitis Patient During Treatment with Tumor Necrosis Factor-alpha Antagonist.

Hayashida S, Sato S, Shimada Y, Tsuzura H, Ikeda Y, Takahashi S Intern Med. 2020; 59(16):1977-1981.

PMID: 32801271 PMC: 7492116. DOI: 10.2169/internalmedicine.4554-20.


Development of peripheral eosinophilia in inflammatory bowel disease patients on infliximab treated at a tertiary pediatric inflammatory bowel disease center is associated with clinically active disease but does not result in loss of efficacy or....

Zabrowski D, Abraham D, Rosenthal G, Kader H JGH Open. 2020; 4(4):636-641.

PMID: 32782950 PMC: 7411706. DOI: 10.1002/jgh3.12308.


Cutaneous Manifestations of Reactions to Biologics.

Otani I, Levin A, Banerji A Curr Allergy Asthma Rep. 2018; 18(2):12.

PMID: 29464437 DOI: 10.1007/s11882-018-0764-z.